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Previews
Of Snakes, Snails, and Surrogates
The high-resolution structure of a synthetic 13-residue the loops lining the acetylcholine binding site and con-
tains the binding site motif YXCC.peptide in a tight complex with -bungarotoxin con-
forms to the  hairpin structure of a closely related HAP is a modification of a peptide selected for -bun-
garotoxin binding from a phage-display peptide librarysegment in the ACh binding protein and reveals how
the ACh binding protein and the homologous nicotinic and corresponds to 187–200 of Torpedo acetylcholine
receptor. The affinity for -bungarotoxin of HAP is twoACh receptors bind -bungarotoxin at their ACh bind-
ing sites. orders of magnitude greater than that of the lead pep-
tide. The aligned sequences of HAP (with a gap) and
Torpedo 187–200 have six identical residues and two
more residues (SS and CC) that are conservative substi-As far as I know, escargot is not on the Formosan krait’s
menu. Nevertheless, the krait’s venom contains the tutes. A neuronal nicotinic receptor that binds -bun-
garotoxin is a homopentamer of the 7 subunit, andpolypeptide -bungarotoxin that binds to an acetylcho-
line binding protein secreted by glial cells in a fresh (7)184–196 and HAP share six identical residues and
three more residues that are conservative substitutes.water snail. The kraits and other elapid snakes lunch on
vertebrate prey, and the -neurotoxins in their venoms Curiously, HAP and the isosteric segment of the acetyl-
choline binding protein share only three identical resi-are high affinity competitive inhibitors of nicotinic acetyl-
choline receptors in striated muscle. The -neurotoxins, dues and two conservative substitutes.
The “short” -neurotoxins, like erabutoxin, containof which -bungarotoxin is the most potent example,
have been indispensable tools in the characterization three loops or “fingers” extending from a globular core
crosslinked by four disulfides. The “long” -neurotoxins,of acetylcholine receptors (Corringer et al., 2000; Karlin
and Akabas, 1995). Recently, our understanding of ace- like -bungarotoxin, are homologous to the short toxins,
but include a fifth disulfide in finger 2 and a C-terminaltylcholine binding sites became much clearer with the
publication of a high-resolution structure of the snail tail, which forms finger 4. The -neurotoxins are mem-
bers of the “three-finger-protein” family (Tsetlin, 1999).acetylcholine binding protein (Brejc et al., 2001). This
water-soluble protein is a homopentamer of a subunit The crystal structure shows that HAP fits snugly into
-bungarotoxin, contacting fingers 1, 2, and 4. Most ofthat is homologous to the N-terminal, extracellular half
of the subunits of the acetylcholine receptors. All of the residues implicated in the binding of both long and
short -neurotoxins are in finger 2, and HAP makes thethe residues that were previously implicated by affinity
labeling and mutagenesis in the binding of acetylcholine shortest and most numerous contacts with finger 2. Two
invariant residues in finger 2, D30, and R36, make closeby nicotinic receptors are aligned with identical residues
in the sequence of the acetylcholine binding protein. contact with HAP residues Y190, S192, and S193 (num-
bered according to the aligned Torpedo sequence). TheNow we can see these residues arrayed in three dimen-
sions. serines are substitutes for C192 and C193, in the YXCC
binding site motif. In addition, HAP Y189, just beforeMuscle-type acetylcholine receptors are pentamers
of four types of subunits in the cyclic order  (Cor- Y190XSS, makes two H bonds from its hydroxyl to HAP
residues. Receptors that bind -bungarotoxin with highringer et al., 2000; Karlin and Akabas, 1995). The recep-
tors’ two acetylcholine binding sites are in the interfaces affinity have either Tyr or Phe at position 189; substitu-
tion of nonaromatic residues at this position can preventbetween  and  and between  and . Short fragments
of  that include the sequence YXCC, an invariant motif binding (Harel et al., 2001).
Because of the exact structural overlap of the firstat the ACh binding site, bind -bungarotoxin, albeit in
most cases with affinities orders of magnitude less than twelve residues of HAP and residues 182–193 of the
snail acetylcholine binding protein, the structure of thethe affinity of the entire receptor complex for this toxin
(Samson et al., 2001, and see references therein). Rela- HAP--bungarotoxin complex can be superposed on
the structure of the acetylcholine binding protein, pro-tively low affinities of -bungarotoxin for short -subunit
fragments might be expected, both because the frag- viding a model of the binding of the toxin to the whole
protein. By the homology of the binding protein to thements include only three of six key acetylcholine binding
residues in  and none of the residues in  and  that acetylcholine receptors, this superposition model re-
veals the probable mode of -bungarotoxin binding tocontribute to acetylcholine binding (Corringer et al.,
2000) and because they are too short to have a single the receptors. In the model, 18% (760 A˚2) of the accessi-
ble surface of the free toxin is buried in the binding site.conformation. Could such fragments provide the mech-
anism for the binding of the snake toxins? The bulbous tip of loop 2 appears stuck in the binding
site cavity between adjacent subunits. The rest of theIn this issue of Neuron, Fuchs and her collaborators
(Harel et al., 2001) describe a synthetic peptide of 13 toxin extends radially from the outside of the cylindrical
pentamer away from the axis.residues (called the high affinity peptide or HAP) that
binds to-bungarotoxin with an equilibrium dissociation As in the complex with HAP, in the model the invariant
toxin residues D30 and R36 are close to the acetylcho-constant of 2 nM, within the range of dissociation con-
stants (0.01–10 nM) for the binding of toxin by intact line binding site residues Y190, C192, and C193. Other
-bungarotoxin residues that affect binding, W28, F32,receptors. They crystallized the -bungarotoxin-HAP
complex and solved its structure to 1.8 A˚ resolution. V39, and P68 (Antil-Delbeke et al., 2000), are also close
to residues in the acetylcholine binding protein. Acetyl-The bound HAP forms a  hairpin that superposes on
the structure of the corresponding segment in the snail choline binding protein residues corresponding to re-
ceptor residues 36–38 and 181–184, on the comple-acetylcholine binding protein. This segment is one of
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M., Smit, A.B., Brejc, K., Sixma, T.K., Katchalski-Katzir, E., et al.protein D161, the equivalent of D174 and D180, which
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play a role in acetylcholine binding (Corringer et al.,
Karlin, A., and Akabas, M.H. (1995). Neuron 15, 1231–1244.2000; Karlin and Akabas, 1995). Other evidence indi-
Osaka, H., Malany, S., Molles, B.E., Sine, S.M., and Taylor, P. (2000).cates that some charged residues in toxin interact with
J. Biol. Chem. 275, 5478–5484.
uncharged residues in receptor and vice versa (Osaka
Samson, A.O., Chill, J.H., Rodriguez, E., Scherf, T., and Anglister,et al., 2000).
J. (2001). Biochemistry 40, 5464–5473.
There are subtleties in the binding of the various
Sine, S.M. (1997). J. Biol. Chem. 272, 23521–23527.
-neurotoxins that are not settled by the model. For
Spura, A., Russin, T.S., Freedman, N.D., Grant, M., McLaughlin, J.T.,example, there are core residues in the toxins that are
and Hawrot, E. (1999). Biochemistry 38, 4912–4921.
important in their binding to both muscle-type Torpedo
Spura, A., Riel, R.U., Freedman, N.D., Agrawal, S., Seto, C., andreceptor and neuronal-type 7 receptor, but there are
Hawrot, E. (2000). J. Biol. Chem. 275, 22452–22460.
other toxin residues that affect binding to one but not
Sullivan, D.A., and Cohen, J.B. (2000). J. Biol. Chem. 275, 12651–
the other receptor (Antil-Delbeke et al., 2000). Also, the 12660.
short and long -neurotoxins have a core of identical
Tsetlin, V. (1999). Eur. J. Biochem. 264, 281–286.
residues that are involved in binding, but each type has
unique residues important in binding (Antil et al., 1999;
Spura et al., 2000). Hence, the dispositions in the binding
site of the two types of toxin are not identical.
Other data indicate that even with toxin bound in the A Novel Cyclin Provides a Link
binding site, there is still some wiggle room. Receptor between Dopamine and
residues 183–198 were mutated one at a time to Cys.
RNA ProcessingOnly one of these mutants did not express. Covalent
attachment to these Cys of a number of different moie-
ties—neutral, negatively charged, and even one posi-
tively charged—did not block toxin binding. Only the Regulation of gene expression by dopamine may play
attachment to the Cys of positively charged quaternary an important role in learning, reward, and addiction.
ammonium moieties blocked toxin binding (Spura et al., Hyman and colleagues now report the characteriza-
1999). A similar result was obtained with the Cys mutant tion of ania-6, a novel cyclin that associates with RNA
of L119, a residue in the complementary surface of the polymerase II and is induced by dopamine or cocaine
binding site that interacts with toxin (Sine, 1997). The in the neostriatum. Ania-6 may thus provide a link
acetylcholine binding site responds in a special way to between dopamine and gene expression at the level
quaternary ammonium groups, and the block of toxin of mRNA processing.
binding by the tethered quaternary ammonium moieties
may involve conformational changes as well as steric Dopamine is a slow-acting neurotransmitter that plays
hindrance (Karlin and Akabas, 1995; Sullivan and Cohen, a critical role in the modulation of neuronal function.
2000). Perturbations in dopaminergic neurotransmission have
There are many steps on the way to enlightenment. been implicated in many human neurological and psy-
Fuchs and her coworkers determined the structure of a chiatric disorders, including Parkinson’s and Hunting-
complex of -bungarotoxin with a short synthetic pep- ton’s disease, schizophrenia, and ADHD. Moreover,
tide; the peptide mimics a segment of the snail acetyl- psychoactive drugs including cocaine, amphetamine,
choline binding protein solved to high-resolution; the opiates, and nicotine influence dopaminergic neuro-
acetylcholine binding protein is homologous to the ace- transmission, and this is likely to contribute to drug
tylcholine receptors; and thereby deep insight is pro- addiction. A major target for midbrain dopaminergic
vided into the molecular mechanism of action of snake neurons is the neostriatum, and this brain region has
-neurotoxins. been utilized extensively to elucidate the actions of do-
pamine. The medium spiny neurons of the neostriatum
Arthur Karlin contain both the D1 and D2 classes of dopamine recep-
Center for Molecular Recognition tor, G protein-coupled receptors that are components
Columbia University of signaling cascades involving primarily cAMP and Ca2
630 West 168th Street and that directly and indirectly control the activity of ion
New York, New York 10032 channels and ligand-gated receptors (Greengard et al.,
1999). Modulation of dopamine signaling is also coupled
Selected Reading to the regulation of gene expression. Both D1 and D2
receptor activation leads to increased phosphorylation of
Antil, S., Servent, D., and Menez, A. (1999). J. Biol. Chem. 274,
the transcription factor CREB and, in turn, leads to in-34851–34858.
creased expression of c-fos and fos-related genes. BothAntil-Delbeke, S., Gaillard, C., Tamiya, T., Corringer, P.J., Changeux,
transient and long-lasting alterations in gene expressionJ.P., Servent, D., and Menez, A. (2000). J. Biol. Chem. 275, 29594–
are also observed in response to psychostimulants and29601.
may be involved in drug addiction (Nestler, 2001).Brejc, K., van Dijk, W.J., Klassen, R.V., Schuurmans, M., van der
Oost, J., Smit, A.B., and Sixma, T.K. (2001). Nature 411, 269–276. In an earlier study, Hyman, Gerfen, and coworkers
